Related Experiment Video
Updated: Aug 9, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension
Tetsuya Oshima1, Ryoji Ozono, Yoko Yano
1Department of Clinical Laboratory Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan. teto@hiroshima-u.ac.jp
Insights
T-type calcium channel blockers, unlike L-type blockers, significantly improved endothelial function in essential hypertension patients. Efonidipine reduced oxidative stress markers, suggesting a novel therapeutic approach for hypertension-related vascular dysfunction.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Pharmacology
Background:
- Essential hypertension is characterized by impaired endothelial function.
- Voltage-gated T-type Ca2+ channels, but not L-type, are present in the vascular endothelium.
Purpose of the Study:
- To investigate the role of T-type Ca2+ channels in endothelial dysfunction in essential hypertension.
- To compare the effects of a T- and L-type Ca2+ channel blocker (efonidipine) versus an L-type Ca2+ channel blocker (nifedipine) on endothelial function.
Main Methods:
- Flow-mediated vasodilation (FMD) and nitroglycerin (NTG)-induced vasodilation were assessed in 40 hypertensive patients and 20 controls.
- Patients received either efonidipine or nifedipine for 12 weeks.
- Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde-modified LDL were measured.
Main Results:
- Hypertensive patients showed attenuated FMD compared to controls.
- Both efonidipine and nifedipine similarly reduced mean blood pressure.
- Efonidipine significantly improved the endothelial function index (FMD/NTG) and reduced oxidative stress markers (8-OHdG, modified LDL), while nifedipine did not.
Conclusions:
- T-type Ca2+ channel blockade, exemplified by efonidipine, may improve endothelial dysfunction in essential hypertension.
- The improvement in endothelial function by efonidipine appears linked to a reduction in oxidative stress.
- L-type Ca2+ channel blockade alone may not be sufficient to restore endothelial function in this patient group.
Abstract:
Endothelial function is impaired in essential hypertension. T-type but not L-type voltage-gated Ca2+ channels were detected in the vascular endothelium. The purpose of the present study was to clarify the role of T-type Ca2+ channels in endothelial function. We studied flow-mediated vasodilation (FMD) and sublingual nitroglycerin (NTG)-induced vasodilation in the brachial artery. Forty patients with essential hypertension were randomly assigned to treatment with efonidipine, a T- and L-type Ca2+ channel blocker, or with nifedipine, an L-type Ca2+ channel blocker. Twenty healthy normotensive individuals were included as a control group. In patients with essential hypertension, FMD was attenuated and NTG was similar that of compared to healthy controls. After 12 weeks, the decrease in mean blood pressure in the efonidipine and nifedipine groups were similar. The endothelial function index, a ratio of FMD/NTG, was significantly increased by efonidipine (73 +/- 24 to 94 +/- 20%) but unchanged by nifedipine. Urinary excretion 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde-modified low-density lipoprotein (LDL) were decreased by efonidipine but unchanged by nifedipine. These results suggest that a T-type Ca2+ channel blocker, but not an L-type Ca2+ channel blocker, may improve vascular endothelial dysfunction in patients with essential hypertension via a reduction in oxidative stress.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Types of β-Blockers
Antihypertensive Drugs: Thiazide-Class Diuretics